Corteva (NYSE:CTVA) Issues Earnings Results, Meets Expectations

Corteva (NYSE:CTVA) posted its earnings results on Tuesday. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22, FiscalAI reports. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 9.19% and a return on equity of 9.37%. The firm’s revenue was down 1.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.32 EPS. Corteva updated its FY 2026 guidance to 3.450-3.700 EPS.

Corteva Price Performance

NYSE CTVA opened at $73.52 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.58 and a quick ratio of 1.07. The stock has a market capitalization of $49.68 billion, a price-to-earnings ratio of 31.42, a PEG ratio of 1.86 and a beta of 0.75. The business’s fifty day moving average price is $68.44 and its 200-day moving average price is $68.35. Corteva has a 1-year low of $53.40 and a 1-year high of $77.41.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. Corteva’s dividend payout ratio (DPR) is 30.77%.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. UBS Group lowered their price target on shares of Corteva from $85.00 to $81.00 and set a “buy” rating on the stock in a report on Thursday, October 30th. Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. Argus raised Corteva to a “strong-buy” rating in a report on Friday, January 16th. Bank of America raised their price objective on shares of Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Finally, Wells Fargo & Company lowered their target price on shares of Corteva from $80.00 to $77.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 11th. Two analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $79.58.

Hedge Funds Weigh In On Corteva

Several hedge funds and other institutional investors have recently modified their holdings of the business. Brighton Jones LLC grew its stake in shares of Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after buying an additional 11,760 shares in the last quarter. Woodline Partners LP lifted its position in shares of Corteva by 40.3% during the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after buying an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after acquiring an additional 980 shares during the last quarter. Cresset Asset Management LLC boosted its position in shares of Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after purchasing an additional 181 shares during the period. Finally, Jump Financial LLC purchased a new position in shares of Corteva during the second quarter worth approximately $1,464,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.